Brought to you by 
Pfizer acquires Pharmacia in $59bn all stock deal
19 Nov 2012
Executive Summary
Pfizer will buy Pharmacia in a tax-free stock-for-stock transaction worth $59bn. For each Pharmacia outstanding share, Pfizer will issue 1.4 shares of its own stock, worth $46.60 based on Pfizer's 10-day average market price--a 33% premium over Pharmacia's market average.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Contract
- Partial Acquisition
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Pfizer acquires Pharmacia in $59bn all stock deal
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice